Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,604,774 shares of GMED stock, worth $217 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,604,774
Previous 2,635,851
1.18%
Holding current value
$217 Million
Previous $181 Million
3.22%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding GMED
# of Institutions
479Shares Held
104MCall Options Held
183KPut Options Held
57.3K-
Vanguard Group Inc Valley Forge, PA10.6MShares$887 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$863 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07MShares$584 Million0.27% of portfolio
-
State Street Corp Boston, MA3.57MShares$298 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.58MShares$215 Million0.03% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.43B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...